A study evaluating effect of antiviral treatment, pre existing diseases and sociodemographic factors on the risk of influenza related complications and healthcare utilization.
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2017
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 09 Oct 2017 New trial record